Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Interest & Investment Income (2016 - 2025)

Adma Biologics (ADMA) has disclosed Interest & Investment Income for 13 consecutive years, with $487000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 18.56% year-over-year to $487000.0, compared with a TTM value of $1.9 million through Dec 2025, down 10.78%, and an annual FY2025 reading of $1.9 million, down 10.78% over the prior year.
  • Interest & Investment Income was $487000.0 for Q4 2025 at Adma Biologics, up from $376000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $666000.0 in Q3 2024 and bottomed at $2269.0 in Q2 2022.
  • Average Interest & Investment Income over 5 years is $283250.0, with a median of $380000.0 recorded in 2024.
  • The sharpest move saw Interest & Investment Income plummeted 91.11% in 2021, then surged 25186.2% in 2023.
  • Year by year, Interest & Investment Income stood at $2759.0 in 2021, then fell by 12.03% to $2427.0 in 2022, then soared by 25186.2% to $613696.0 in 2023, then fell by 2.56% to $598000.0 in 2024, then fell by 18.56% to $487000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for ADMA at $487000.0 in Q4 2025, $376000.0 in Q3 2025, and $400000.0 in Q2 2025.